IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC)

NCT04575610 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class

Stopped Study terminated due to lack of enrollment reflecting the decrease in number of COVID infections. There were no safety and/or efficacy concerns involved in the decision to stop enrollment.

Conditions

Interventions

Sponsor

Yale University

Collaborators